John Hancock Strategic Series has recently filed its NPORT-P report, providing an update on its financial status as of August 31, 2026. This filing is significant as it reveals the company’s total assets amounting to approximately $337 million. The report underscores the company's commitment to transparency and regulatory compliance, which are crucial in the investment management industry.
John Hancock Strategic Series, an investment entity incorporated in Massachusetts, operates under the Central Index Key (CIK) 0000792858. The company primarily focuses on managing investment portfolios, adhering to the regulations set forth by the SEC, specifically under the 1940 Act. As of the latest filing, the company has been active in submitting various reports, including multiple NPORT-P forms on the same date, October 29, 2026.
The recent filing highlights the company’s total assets of $337,150,468.11, with total liabilities reported at $2,850,017.68, leading to net assets of $334,300,450.43. This financial snapshot is critical for stakeholders as it reflects the company’s ability to manage its resources effectively.
"The filing does not say what happens next."
In terms of investment strategy, the report details the asset allocation and performance metrics of the John Hancock Managed Account Shares Securitized Debt Portfolio. The filing indicates a focus on various securities, including investments in government-backed mortgage associations, which constitute a significant portion of the portfolio. This diversification strategy is essential for mitigating risks associated with market fluctuations.
The filing also provides insights into the monthly total returns, showcasing a monthly return of 0.17% in the first month reported, followed by a slight decline of -0.04% in the second month, and a recovery to 0.07% in the third month. These figures are vital for current and potential investors as they assess the performance of the fund.
As the investment management industry continues to evolve, the importance of regulatory compliance and transparency cannot be overstated. This filing serves as a reminder of the ongoing obligations that investment firms have to their investors and regulators. Companies like John Hancock Strategic Series must navigate a competitive landscape where trust and accountability are paramount.
Looking ahead, stakeholders will be keen to monitor future filings and any strategic decisions made by the company. The financial health and operational strategies of John Hancock Strategic Series will undoubtedly influence its standing in the investment management sector.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






